Investor Presentation
adj. ebitda reconciliation
AR
Loss from continuing operations (GAAP)
Incremental costs to acquire cannabis inventory in business combination
Interest (within COGS)
Depreciation and amortization
Acquisition and Transaction Costs
Stock-based compensation, non-cash
all amounts in USD, in thousands
Start-up costs¹
(Gain) loss on sale of assets
Other²
three months ended September 30
2023
2022
(1,451)
(19,462)
776
22,019
(1,182)
3,410
2,909
22
1,924
29,878
CSE:AYR.A | OTC:AYRWF
28,427
486
1,694
19,549
965
Adjusted EBITDA from continuing operations (non-GAAP)
1) Includes costs to prepare a location for its intended use, including facilities not yet operating at scale. Start-up costs are expensed as incurred and are not indicative of ongoing operations.
2) Other non-core costs including non-operating adjustments, severance costs and non-cash inventory write-downs
9,359
2,930
1,810
1,337
38,130
18,668
17View entire presentation